These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21624753)

  • 1. Alteration of brain activation patterns in nonallergic rhinitis patients using functional magnetic resonance imaging before and after treatment with intranasal azelastine.
    Bernstein JA; Hastings L; Boespflug EL; Allendorfer JB; Lamy M; Eliassen JC
    Ann Allergy Asthma Immunol; 2011 Jun; 106(6):527-32. PubMed ID: 21624753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.
    Lieberman P; Kaliner MA; Wheeler WJ
    Curr Med Res Opin; 2005 Apr; 21(4):611-8. PubMed ID: 15899111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intranasal azelastine on substance P release in perennial nonallergic rhinitis patients.
    Gawlik R; Jawor B; Rogala B; Parzynski S; DuBuske L
    Am J Rhinol Allergy; 2013; 27(6):514-6. PubMed ID: 24274229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of azelastine versus triamcinolone nasal spray in allergic and nonallergic rhinitis.
    Kalpaklioglu AF; Kavut AB
    Am J Rhinol Allergy; 2010; 24(1):29-33. PubMed ID: 20109317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azelastine desensitization of transient receptor potential vanilloid 1: a potential mechanism explaining its therapeutic effect in nonallergic rhinitis.
    Singh U; Bernstein JA; Haar L; Luther K; Jones WK
    Am J Rhinol Allergy; 2014; 28(3):215-24. PubMed ID: 24980233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of azelastine nasal spray (Astelin NS) for seasonal allergic rhinitis: a 4-week comparative multicenter trial.
    LaForce C; Dockhorn RJ; Prenner BM; Chu TJ; Kraemer MJ; Widlitz MD; D'Eletto TA; Freitag JJ
    Ann Allergy Asthma Immunol; 1996 Feb; 76(2):181-8. PubMed ID: 8595539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update regarding the treatment of nonallergic rhinitis.
    Daramola OO; Kern RC
    Curr Opin Otolaryngol Head Neck Surg; 2016 Feb; 24(1):10-4. PubMed ID: 26731682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age.
    Wober W; Diez Crespo CD; Bähre M
    Arzneimittelforschung; 1997 Jul; 47(7):841-4. PubMed ID: 9272242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis.
    Banov CH; Lieberman P;
    Ann Allergy Asthma Immunol; 2001 Jan; 86(1):28-35. PubMed ID: 11206234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal treatment of perennial allergic rhinitis. Comparison of azelastine nasal spray and budesonide nasal aerosol.
    Gastpar H; Aurich R; Petzold U; Dorow P; Enzmann H; Gering R; Köchy HP; Philippe A; Renz W; Wendenburg G
    Arzneimittelforschung; 1993 Apr; 43(4):475-9. PubMed ID: 8494580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability.
    Bernstein JA
    Curr Med Res Opin; 2007 Oct; 23(10):2441-52. PubMed ID: 17723160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
    Ratner PH; Hampel F; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):74-81. PubMed ID: 18254486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of azelastine nasal spray in patients with allergic rhinitis compared to placebo and budesonide.
    Dorow P; Aurich R; Petzold U
    Arzneimittelforschung; 1993 Aug; 43(8):909-12. PubMed ID: 8105785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of intranasal azelastine and beclomethasone on the symptoms and signs of nasal allergy in patients with perennial allergic rhinitis.
    Davies RJ; Lund VJ; Harten-Ash VJ
    Rhinology; 1993 Dec; 31(4):159-64. PubMed ID: 7908144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azelastine nasal spray as adjunctive therapy to azelastine tablets in the management of seasonal allergic rhinitis.
    Weiler JM; Meltzer EO
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):327-32. PubMed ID: 9357378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of long-term efficacy and tolerability of azelastine nasal spray in the treatment of perennial allergic rhinitis.
    Gastpar H; Dorow P; Aurich R; Petzold U
    Arzneimittelforschung; 1993 Jul; 43(7):771-6. PubMed ID: 8103660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis.
    Carr WW; Ratner P; Munzel U; Murray R; Price D; Canonica GW; Mullol J; Virchow JC; Lieberman P; Meltzer E; Bachert C
    Allergy Asthma Proc; 2012; 33(6):450-8. PubMed ID: 23127291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azelastine nasal spray: a review of pharmacology and clinical efficacy in allergic and nonallergic rhinitis.
    Lieberman PL; Settipane RA
    Allergy Asthma Proc; 2003; 24(2):95-105. PubMed ID: 12776442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term, randomized safety study of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) in subjects with chronic rhinitis.
    Berger WE; Shah S; Lieberman P; Hadley J; Price D; Munzel U; Bhatia S
    J Allergy Clin Immunol Pract; 2014; 2(2):179-85. PubMed ID: 24607046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for the intranasal formulation of azelastine hydrochloride/fluticasone propionate in the treatment of allergic rhinitis.
    Ridolo E; Montagni M; Melli V; Bonzano L; Incorvaia C; Canonica GW
    Ther Deliv; 2015; 6(6):653-9. PubMed ID: 25913181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.